Skip to main content
Terug
Watch Compare

ACCENDRA HEALTH INC/VA/

Datakwaliteit: 83%
ACH
NYSE Wholesale Trade Durable Goods Wholesale
€ 2,66
▲ € 0,09 (3,31%)
Marktkapitalisatie: 202,94 M
Prijs
€ 2,66
Marktkapitalisatie
202,94 M
Dagbereik
€ 2,55 — € 2,67
52-Weeksbereik
€ 1,84 — € 9,55
Volume
343.842
Openen € 2,54
50D / 200D Gem.
€ 2,32
14,62% above
50D / 200D Gem.
€ 4,24
37,38% below

Quick Summary

Belangrijkste Punten

Revenue declined -27,11% annually over 5 years
Revenue growth is decelerating — 1Y growth trails 5Y average by 47,08%
Capital efficient — spends only 6,91% of revenue on capex
ROIC of 1,42% — low return on invested capital
Interest coverage of 0,26× — tight debt servicing

Groei

Revenue Growth (5Y)
-27,11%
Onder sectorgemiddelde (257,90%)
Revenue (1Y)-74,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC1,42%
Net Margin-39,85%
Op. Margin0,99%

Veiligheid

Debt / Equity
N/A
Current Ratio0,86
Interest Coverage0,26

Waardering

PE (TTM)
-0,18
Boven sectorgemiddelde (-27,54)
P/B RatioN/A
EV/EBITDA0,70
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Wholesale Trade sector mediaan (3 peers)
Metriek Aandeel Sector Mediaan
P/E -0,2 -27,5
P/B — 1,6
ROE % — -2,8
Net Margin % -39,9 -199494,9
Rev Growth 5Y % -27,1 257,9
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -74,19% Revenue Growth (3Y) -48,30%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -27,11% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,76 B Net Income (TTM) -1,10 B
ROE N/A ROA -26,88%
Gross Margin N/A Operating Margin 0,99%
Net Margin -39,85% Free Cash Flow (TTM) N/A
ROIC 1,42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,86
Interest Coverage 0,26 Asset Turnover 0,67
Working Capital -334,29 M Tangible Book Value -1,82 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,18 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,07
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 0,70 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 202,94 M Enterprise Value 170,11 M
Per Share
EPS (Diluted TTM) -14,31 Revenue / Share 36,13
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6,91% FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum -47,08

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,76 B 10,70 B 10,33 B 9,96 B 9,79 B
Net Income -1,10 B -362,69 M -41,30 M 22,39 M 221,59 M
EPS (Diluted) -14,31 -4,73 -0,54 0,29 2,94
Gross Profit — 2,22 B 2,13 B 1,83 B 1,51 B
Operating Income 27,46 M -207,77 M 104,51 M 142,91 M 368,47 M
EBITDA — — — — —
R&D Expenses — 13,00 M 13,20 M — —
SG&A Expenses 1,07 B 1,91 B 1,81 B 1,63 B 1,12 B
D&A 214,52 M 264,78 M 287,38 M 228,67 M 90,62 M
Interest Expense 107,18 M 143,80 M 157,92 M 128,89 M 48,09 M
Income Tax 729.000,0 5,33 M -13,43 M -11,50 M 55,17 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,45 B 4,66 B 5,09 B 5,39 B 3,54 B
Total Liabilities 2,91 B 4,09 B 4,17 B 4,44 B 2,60 B
Shareholders' Equity -460,98 M 565,23 M 924,17 M 945,60 M 938,50 M
Total Debt — — — — —
Cash & Equivalents 281,99 M 49,38 M 243,04 M 69,47 M 55,71 M
Current Assets 547,87 M 2,02 B 2,10 B 2,30 B 2,32 B
Current Liabilities 947,08 M 1,87 B 1,89 B 1,57 B 1,34 B